Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma

Anna E.C.A.B. Willemsen; Carla M.L. Van Herpen; Pieter Wesseling; Peter Bult; Hanneke W.M. Van Laarhoven

doi:10.3109/0284186X.2010.491088

Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma

Anna E.C.A.B. Willemsen, Carla M.L. Van Herpen, Pieter Wesseling, Peter Bult, Hanneke W.M. Van Laarhoven

Onderzoeksoutput: Bijdrage aan tijdschrift › Artikel › peer review

11 Citaten (Scopus)

Originele taal-2	Engels
Pagina's (van-tot)	462-465
Aantal pagina's	4
Tijdschrift	Acta Oncologica
Volume	50
Nummer van het tijdschrift	3
DOI's	https://doi.org/10.3109/0284186X.2010.491088
Status	Gepubliceerd - apr. 2011
Extern gepubliceerd	Ja

Toegang tot document

10.3109/0284186X.2010.491088

Citeer dit

@article{ae0726153203445db1ac54c2fbc1c90f,

title = "Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma",

author = "Willemsen, \{Anna E.C.A.B.\} and \{Van Herpen\}, \{Carla M.L.\} and Pieter Wesseling and Peter Bult and \{Van Laarhoven\}, \{Hanneke W.M.\}",

year = "2011",

month = apr,

doi = "10.3109/0284186X.2010.491088",

language = "English",

volume = "50",

pages = "462--465",

journal = "Acta Oncologica",

issn = "0284-186X",

publisher = "Medical Journals Sweden AB",

number = "3",

}

TY - JOUR

T1 - Fatal thrombotic microangiopathy after a single dose of gemcitabine as fourth-line palliative treatment for metastasized ductal breast carcinoma

AU - Willemsen, Anna E.C.A.B.

AU - Van Herpen, Carla M.L.

AU - Wesseling, Pieter

AU - Bult, Peter

AU - Van Laarhoven, Hanneke W.M.

PY - 2011/4

Y1 - 2011/4

UR - https://www.scopus.com/pages/publications/79952667992

U2 - 10.3109/0284186X.2010.491088

DO - 10.3109/0284186X.2010.491088

M3 - Article

C2 - 20799915

AN - SCOPUS:79952667992

SN - 0284-186X

VL - 50

SP - 462

EP - 465

JO - Acta Oncologica

JF - Acta Oncologica

IS - 3

ER -